What will be the projected value of IV Tubing Sets and Accessories Market by 2035?

The IV Tubing Sets and Accessories Market is projected to reach USD 1461.32 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.

What is the expected CAGR of the IV Tubing Sets and Accessories Market during 2026-2035?

The IV Tubing Sets and Accessories Market is expected to grow at a CAGR of 5.5% during the forecast period from 2026 to 2035.

How large was the IV Tubing Sets and Accessories Market in 2025?

The IV Tubing Sets and Accessories Market was valued at USD 849.28 Million in 2025, reflecting strong demand and continued adoption across major industries.

IV Tubing Sets and Accessories Market Growth to 2035

IV Tubing Sets and Accessories Market Overview

The global iv tubing sets and accessories market size was valued at USD 849.28 million in 2025 and is projected to grow from USD 895.99 million in 2026 to USD 1461.32 million by 2035, exhibiting a CAGR of 5.5% during the forecast period.

The IV Tubing Sets and Accessories Market is expanding as healthcare providers place greater emphasis on reliable vascular access, medication safety, infection prevention, closed fluid pathways, precise infusion delivery, and reduced nursing workload. Peripheral Intravenous Catheter Insertion is estimated to account for approximately 51% of global demand in 2026 because peripheral access remains the most frequently used approach for short-duration fluids, medications, antibiotics, and perioperative therapy. Modern IV systems increasingly combine catheters, extension tubing, needleless connectors, clamps, flow regulators, filters, stopcocks, valves, and securement components into integrated configurations. Closed peripheral systems can combine as many as 4 traditionally separate components within a single device, reducing connection steps and potential manipulation. Current administration sets are available with approximately 15-micron fluid filters, 0.2-micron filters for selected therapies, tubing lengths exceeding 250 cm, and multiple needle-free injection sites. The market is also shifting toward PVC-free, DEHP-free, latex-free, auto-priming, anti-free-flow, and air-stop technologies as hospitals seek safer fluid delivery and standardized infusion workflows.

The United States represents a major IV Tubing Sets and Accessories market because of its large hospital system, high procedure volumes, infusion therapy infrastructure, oncology services, home and long-term care, ambulatory surgery, and extensive use of central and peripheral vascular access. North America is estimated to account for approximately 39% of global demand in 2026, with the United States representing most regional consumption. Current closed peripheral catheter platforms can remain in place for median periods approaching 144 hours in selected clinical studies compared with around 96 hours for conventional open configurations. Pump-compatible primary IV sets can maintain specified delivery accuracy for periods up to approximately 96 hours under defined operating conditions. Hospitals are also adopting administration sets with automatic air-stop functions, backcheck valves, needleless injection ports, and tubing lengths ranging from approximately 104 inches to 134 inches. These features help reduce repetitive nursing tasks while supporting safer medication administration. U.S. procurement increasingly favors standardized systems that integrate with smart pumps and electronic drug libraries.

Download Free sample to learn more about this report.

Key Findings

Leading Product Type: Peripheral Intravenous Catheter Insertion is expected to lead with approximately 51% market share in 2026 because peripheral access remains central to short-term fluids, antibiotics, medication, and perioperative therapy.
Leading Application: Hospitals are projected to account for approximately 48% of demand as inpatient medication delivery, surgery, oncology, emergency treatment, critical care, and hydration require extensive IV infrastructure.
Leading Region: North America is estimated to hold approximately 39% market share, supported by advanced infusion infrastructure, high procedure volumes, smart-pump use, vascular-access teams, and established hospital networks.
Fastest Growing Region: Asia Pacific is projected to expand at approximately 7.1% annually as hospital capacity, infusion therapy, oncology care, surgery, diagnostic services, and domestic medical-device manufacturing increase.
Technology Trend: Closed peripheral systems are gaining adoption by combining up to 4 traditionally separate vascular-access components into one integrated configuration that reduces handling and connection steps.
Market Driver: Longer catheter dwell is improving workflow economics, with selected closed peripheral systems demonstrating median dwell times approaching 144 hours compared with approximately 96 hours for open configurations.
Competitive Landscape: Safety-focused administration sets increasingly incorporate approximately 0.2-micron or 15-micron filtration, needleless ports, air-stop functions, and material formulations without DEHP or PVC.
Future Outlook: The market is expected to grow at a 5.5% CAGR through 2035 as closed systems, smart infusion, outpatient therapy, PICC use, safety connectors, and material innovation expand.

Latest Trends

Closed vascular-access systems and needleless connectivity represent major trends in the IV Tubing Sets and Accessories Market. Traditional peripheral IV therapy may require a catheter, extension line, securement device, and needle-free connector to be assembled separately. Newer closed systems can integrate 4 of these elements, reducing the number of connections handled during insertion and subsequent therapy. This approach can support longer catheter dwell, fewer restarts, and lower exposure to blood during setup. Needleless extension sets are increasingly available with multiple connector technologies, various tubing lengths, and high-pressure capability for specialized procedures. Selected extension sets can support pressure injection at approximately 300 psi and flow approaching 10 mL per second. Hospitals increasingly favor standardized closed configurations because every additional connection can create opportunities for disconnection, contamination, dead space, medication incompatibility, or nursing error. Integrated designs therefore support both infection-control and workflow objectives.

Safer tubing materials and automated fluid-management features represent another important trend. Manufacturers are expanding IV administration sets not made with PVC, DEHP, natural rubber latex, or combinations of these materials. Auto air-stop filters are increasingly incorporated into primary infusion sets to prevent the fluid column from falling completely when an IV container empties, helping reduce line repriming requirements. Current systems can use approximately 20 drops per mL drip chambers, priming volumes between about 24 mL and 30 mL, and tubing lengths from approximately 264 cm to 340 cm. Specialized infusion sets also incorporate 0.2-micron, 1.2-micron, or 15-micron filters depending on therapeutic requirements. These improvements are complemented by smart-pump integration and wireless drug-library management, shifting tubing from a passive disposable toward an engineered component within a controlled medication-delivery ecosystem.

Market Dynamics

Driver

""High volumes of intravenous therapy are sustaining continuous demand for safer disposable access systems.""

The strongest market driver is the widespread use of intravenous therapy across acute and post-acute care. Hospitals account for approximately 48% of market demand in 2026 because IV access is routinely required for hydration, antibiotics, analgesics, chemotherapy, anesthesia, blood products, emergency medication, and intensive-care treatment. Peripheral access is particularly important, representing approximately 51% of product demand because it is simpler and less invasive than central access for shorter therapies. Every catheter placement can require tubing, connectors, extension lines, clamps, caps, filters, or accessories, creating recurring disposable consumption. Healthcare systems increasingly favor integrated systems that minimize manipulation and extend useful catheter dwell. Closed peripheral systems demonstrating dwell periods approaching 144 hours can potentially reduce repeated insertion compared with devices remaining functional for approximately 96 hours, supporting both patient comfort and nursing efficiency.

Restraint

""Intense price pressure on disposable supplies can constrain manufacturer margins and technology adoption.""

A major restraint is the highly price-sensitive nature of IV disposables. Hospitals purchase large numbers of tubing sets, connectors, extension lines, catheters, and accessories and often negotiate through centralized procurement organizations. Even a small unit-cost difference becomes significant when facilities consume thousands of sets each month. Peripheral Intravenous Catheter Insertion represents approximately 51% of demand, making this segment particularly exposed to commodity pricing. Advanced sets containing air-stop filters, needleless ports, specialty materials, or multiple connectors can cost more than basic tubing. Smaller hospitals and healthcare systems in emerging markets may therefore prioritize simple designs where budgets are restricted. Manufacturers must balance additional safety functions with affordability while maintaining sterile manufacturing, packaging integrity, validated flow performance, biocompatibility, and regulatory compliance.

Opportunity

""PICC and long-duration infusion therapy create strong opportunities beyond traditional inpatient IV use.""

PICC Line Insertion provides an important opportunity because patients increasingly receive medium- and long-duration therapies outside conventional inpatient settings. PICC Line Insertion is estimated to represent approximately 18% of product demand in 2026 and supports chemotherapy, long-term antibiotics, parenteral nutrition, and other repeated infusions. Modern PICCs are available in single and multiple lumen configurations and can support medium-to-long-term treatment periods extending beyond 30 days and approaching 90 days in selected products. Associated demand includes extension tubing, needleless connectors, securement, flushing devices, clamps, caps, and specialty administration sets. Specialized Clinics, Skilled Nursing Facilities, and Long Term Care Centers are particularly attractive because more patients are receiving complex therapies outside acute hospitals. Companies that provide complete vascular-access ecosystems can therefore generate recurring accessory demand throughout the therapy period.

Challenge

""Preventing infection, occlusion, air entry, and dosing error remains an ongoing clinical challenge.""

The central challenge is maintaining a safe closed fluid pathway throughout therapy. IV lines may remain connected for hours or days and can be accessed repeatedly for medication administration, blood sampling, flushing, or tubing changes. Each manipulation creates potential for contamination, disconnection, air entry, or medication error. Central Venous Catheter Placement represents approximately 31% of product demand and requires particularly strict handling because infections associated with central access can be clinically serious. Manufacturers are responding with needleless connectors, backcheck valves, automatic air-stop designs, secure locking collars, and filtration. Current primary sets can incorporate 2 or 3 needleless injection sites and use approximately 0.2-micron filters in specialized configurations. The challenge is ensuring these additional components improve safety without increasing dead volume, resistance, connection complexity, or incompatibility with medications.

Download Free sample to learn more about this report.

Segmentation Analysis

The IV Tubing Sets and Accessories Market is segmented by product type into Peripheral Intravenous Catheter Insertion, Central Venous Catheter Placement, and PICC Line Insertion and by application into Hospitals, Ambulatory Surgical Centers, Specialized Clinics, Skilled Nursing Facilities, Long Term Care Centers, and Others. Peripheral Intravenous Catheter Insertion is estimated to account for approximately 51% of demand in 2026, Central Venous Catheter Placement 31%, and PICC Line Insertion 18%. Hospitals represent approximately 48% of application demand, Ambulatory Surgical Centers 15%, Specialized Clinics 13%, Skilled Nursing Facilities 10%, Long Term Care Centers 8%, and Others 6%.

By Types

Peripheral Intravenous Catheter Insertion: Peripheral Intravenous Catheter Insertion is estimated to lead with approximately 51% market share in 2026. Peripheral IV access is widely used for short-duration hydration, antibiotics, medication, anesthesia, emergency treatment, and diagnostic procedures. The accessory ecosystem includes primary tubing, extension sets, needle-free connectors, injection ports, securement components, filters, clamps, and flushing devices. Closed peripheral systems increasingly combine approximately 4 separate functions into one device and can support median dwell durations approaching 144 hours under selected clinical conditions. Longer dwell can reduce repeated insertion and nursing workload. Safety-engineered peripheral devices are also increasingly designed to reduce blood exposure during insertion. Hospitals and Ambulatory Surgical Centers provide particularly strong demand because peripheral access is routinely initiated before procedures and inpatient therapies.

Central Venous Catheter Placement: Central Venous Catheter Placement is estimated to account for approximately 31% of global market demand in 2026. Central lines are used where patients require high-flow access, vasoactive medications, parenteral nutrition, chemotherapy, dialysis-related access, difficult peripheral access, or extended therapy. Central systems commonly require multiple lumens, extension lines, needleless connectors, clamps, stopcocks, securement, and antimicrobial management. Accessory design is important because central catheters may remain in place substantially longer than peripheral devices and can be manipulated many times during treatment. Specialized administration sets are available with approximately 0.2-micron filters and multiple injection sites for complex medication delivery. Hospitals and Specialized Clinics are major users because central access is common in critical care, oncology, and advanced therapy.

PICC Line Insertion: PICC Line Insertion is estimated to represent approximately 18% of global demand in 2026. PICCs provide central venous access through a peripheral vein and are frequently used for medium-to-long-term antibiotics, chemotherapy, parenteral nutrition, and other repetitive infusions. Current PICC portfolios include devices in sizes near 3 Fr and larger, along with single-lumen and multi-lumen designs. Selected products are intended for treatment periods greater than approximately 30 days and extending toward 90 days. PICCs are increasingly placed using ultrasound guidance and tip-position technologies, improving procedural workflow. The category generates sustained demand for extension tubing, flushing accessories, connectors, securement products, caps, and specialty infusion sets throughout therapy. Growth is supported by outpatient and post-acute care.

By Applications

Hospitals: Hospitals are estimated to lead with approximately 48% of global market demand in 2026. Inpatient wards, emergency departments, operating rooms, intensive-care units, oncology centers, maternity departments, and surgical units consume large quantities of IV tubing and access accessories every day. Hospitals require systems compatible with infusion pumps and standardized medication-delivery protocols. Current large-volume infusion systems can maintain specified delivery accuracy of approximately plus or minus 5% across flow rates from around 1 mL per hour to 1,200 mL per hour under defined conditions. Compatible tubing performance can extend up to approximately 96 hours. Hospitals increasingly standardize product families to reduce training requirements and connection variation across departments.

Ambulatory Surgical Centers: Ambulatory Surgical Centers are estimated to represent approximately 15% of market demand in 2026. Patients undergoing same-day surgery commonly receive peripheral IV access for anesthesia, fluids, antibiotics, analgesics, and postoperative medications. The shorter patient stay encourages use of simple, reliable systems that can be inserted quickly and removed after recovery. Peripheral Intravenous Catheter Insertion therefore accounts for the majority of tubing-related consumption within these facilities. Ambulatory centers increasingly use closed catheter systems, needleless connectors, and preconfigured extension tubing to reduce setup steps. Sets measuring approximately 150 cm to 250 cm provide flexibility around operating tables and recovery beds. Growth in outpatient procedures should support continued demand.

Specialized Clinics: Specialized Clinics are estimated to account for approximately 13% of global demand in 2026. Oncology, infusion therapy, rheumatology, gastroenterology, infectious-disease, and specialty medication clinics frequently administer therapies lasting several hours or recurring over weeks. These applications may use peripheral IV access, PICCs, ports, or central catheters depending on therapy duration. Specialty sets can include approximately 0.2-micron filters for selected medications and several needle-free access points for complex protocols. Oncology remains especially important because chemotherapy and biologic infusion require controlled fluid pathways and careful compatibility with tubing materials. Specialized Clinics increasingly favor closed connectors and DEHP-free systems.

Skilled Nursing Facilities: Skilled Nursing Facilities represent approximately 10% of global application demand in 2026. These facilities provide IV antibiotics, hydration, pain medication, nutrition, and other therapies to patients recovering from acute illness or surgery. PICCs and other longer-duration vascular-access devices are important because repeated hospital transfers for infusion can increase cost and inconvenience. Skilled nursing staff therefore require simple connectors, clear tubing, secure clamps, and reliable extension sets. Product standardization is particularly useful because a facility may manage several residents receiving different IV therapies simultaneously. The aging population and increasing transfer of post-acute treatment from hospitals should support sustained demand.

Long Term Care Centers: Long Term Care Centers are estimated to account for approximately 8% of market demand in 2026. Residents may require episodic hydration, antibiotics, nutrition, or chronic medication through peripheral or central access. Products need to support straightforward operation because staffing models differ from acute hospitals. Needleless connectors and preassembled extension sets reduce the number of separate components that must be managed during therapy. PICC systems supporting treatment periods beyond approximately 30 days can be particularly useful for residents requiring prolonged antibiotics. Growth is supported by an increasing elderly population and expansion of long-term clinical services outside hospitals.

Others: Others account for approximately 6% of global application demand in 2026 and include home infusion, emergency medical services, mobile treatment facilities, blood centers, dialysis-related environments, and other healthcare settings. Home infusion is becoming particularly important as selected patients receive antibiotics, nutrition, biologics, and other therapies outside institutional facilities. Compact pumps and preconfigured tubing simplify treatment, but product design must minimize setup complexity. Tubing systems with secure luer-lock connections, backcheck valves, and clearly identified clamps can improve usability. The category is expected to expand as healthcare systems increase decentralized treatment.

Download Free sampleto learn more about this report.

Regional Outlook

North America

North America is estimated to lead the IV Tubing Sets and Accessories Market with approximately 39% share in 2026. The United States and Canada maintain advanced hospital infrastructure, high infusion-pump penetration, extensive oncology services, large ambulatory surgery networks, and substantial post-acute care capacity. Baxter International, Becton Dickinson (CareFusion), ICU Medical, Hospira (Pfizer), B Braun Melsungen, C.R. Bard, Smiths Medical, and other supplied companies maintain established positions across the regional vascular-access and infusion ecosystem. Hospitals are the primary purchasers, but outpatient and long-term therapy increasingly support recurring demand outside acute care.

Safety-focused product development is particularly advanced across North America. Current administration sets are available with AirStop filters, approximately 15-micron standard fluid filters, and 0.2-micron filters for selected therapies. Needleless extension sets can support pressure injection at approximately 300 psi and 10 mL per second. Pump systems can also maintain specified administration-set performance for approximately 96 hours under defined conditions. Health systems increasingly seek tubing not made with DEHP, PVC, BPA, or natural rubber latex where clinically and technically suitable. These requirements should maintain North America's leadership throughout the forecast period.

Europe

Europe is estimated to represent approximately 28% of global market demand in 2026. Germany, France, the United Kingdom, Italy, Spain, the Netherlands, and Nordic countries provide extensive hospital and outpatient infusion infrastructure. B Braun Melsungen, Fresenius Kabi, Vygon, Baxter International, ICU Medical, Nipro, and other manufacturers maintain strong regional distribution. European healthcare systems increasingly focus on infection prevention, reduced material toxicity, waste reduction, standardized connectors, and nursing workflow. PVC-free and DEHP-free administration sets are becoming particularly important in neonatal, oncology, and other sensitive applications.

Central and PICC vascular access provide significant regional demand. Current PICC products are available in configurations extending from approximately 3 Fr single-lumen systems to larger multi-lumen options intended for medium-to-long-term therapy. European hospitals increasingly use ultrasound-guided insertion and dedicated vascular-access teams, improving device selection and catheter placement. Needleless connector standardization is also helping reduce accidental needlestick exposure. As population aging increases infusion requirements, Europe should maintain a substantial market share through 2035 despite comparatively mature hospital infrastructure.

Asia Pacific

Asia Pacific is estimated to account for approximately 25% of global market demand in 2026 and is projected to expand at approximately 7.1% annually, making it the fastest-growing region. China, India, Japan, South Korea, Australia, Indonesia, and Southeast Asia are expanding hospitals, oncology services, Ambulatory Surgical Centers, diagnostic infrastructure, and long-term care. Nipro, Poly Medicure, B Braun Melsungen, Fresenius Kabi, Baxter International, and several regional manufacturers provide growing local production and distribution. India has become particularly important in disposable medical-device manufacturing, supporting both domestic demand and exports.

Regional product portfolios increasingly include advanced infusion sets with auto air-stop systems, needle-free injection sites, flow regulators, micro-infusion configurations, and DEHP-free tubing. One current IV set platform uses an approximately 15-micron filter and 150 cm kink-resistant tubing, while more advanced systems incorporate automatic priming and air-stop functions. Local manufacturing can reduce cost and improve availability in rapidly expanding hospital systems. Asia Pacific's growth should therefore be supported by both healthcare demand and production localization through 2035.

Latin America, Middle East & Africa

Latin America, the Middle East & Africa are estimated to represent approximately 8% of global market demand in 2026. Brazil, Mexico, Saudi Arabia, the UAE, Turkey, South Africa, and large metropolitan healthcare systems account for much of regional consumption. Hospitals remain the dominant application because advanced outpatient infusion infrastructure is less evenly developed than in North America or Europe. Basic peripheral IV sets account for substantial volume, although major private hospitals increasingly procure closed systems, specialty filters, needleless connectors, and smart-pump-compatible tubing.

Affordability and supply reliability are particularly important. Standard infusion sets using approximately 150 cm tubing and 15-micron filters provide practical functionality at competitive cost, while premium facilities increasingly require PVC-free or DEHP-free options. Local distribution networks and public tenders strongly influence purchasing. The region's approximately 8% current share is expected to increase gradually as new hospitals, oncology centers, and private healthcare networks expand. Domestic assembly and regional manufacturing partnerships may improve supply security over the forecast period.

List of Top IV Tubing Sets and Accessories Companies

Baxter International
Hospira (Pfizer)
Becton Dickinson (CareFusion)
B Braun Melsungen
Fresenius Kabi
Smiths Medical
C.R. Bard
ICU Medical
Zyno Medical
Nipro
Poly Medicure
Vygon
Health Line International
Perfect Medical
Dynarex

Top 2 Companies Market Share

Baxter International: Baxter International is estimated to account for approximately 19% of the competitive IV Tubing Sets and Accessories market in 2026. Its position is supported by a broad infusion-system portfolio covering primary, secondary, blood, extension, specialty, and drug-specific sets. Current compatible sets include tubing lengths from approximately 1.9 m to 2.7 m and filter options near 0.2 micron, 1.2 micron, and larger blood-filter ranges. Baxter's integrated infusion-pump ecosystem enables health systems to standardize pumps and tubing across several clinical departments.

B Braun Melsungen: B Braun Melsungen is estimated to hold approximately 17% of the competitive market in 2026. Its infusion portfolio includes administration sets, needleless extension sets, connectors, AirStop technology, and configurations not made with PVC or DEHP. Current CARESAFE sets provide approximately 20 drops per mL, tubing lengths up to about 340 cm, 2 or 3 needleless injection sites, and filtration options around 0.2 micron or 15 microns. Its focus on material safety, closed access, and nursing workflow supports a strong international competitive position.

Investment Analysis

Investment in the IV Tubing Sets and Accessories Market is increasingly directed toward automated extrusion, connector molding, sterilization, closed-system assembly, specialty filtration, medical-grade alternative materials, and smart-pump compatibility. The market's 5.5% CAGR creates steady capacity requirements because most tubing and connectors are single-use products with recurring demand. Peripheral Intravenous Catheter Insertion represents approximately 51% of product demand, making high-volume automated manufacturing particularly important. Manufacturers are investing in vision inspection, automated bonding, leak testing, particulate control, connector dimensional verification, and sterile packaging to improve reliability while reducing labor. Material development is another major investment theme as hospitals increasingly request products not made with PVC, DEHP, BPA, or latex where practical.

Asia Pacific offers the strongest expansion opportunity at approximately 7.1% annual growth, while North America remains the largest existing market with approximately 39% share. Investment in domestic production can improve resilience because hospitals require continuous availability of high-volume disposable tubing. PICC Line Insertion and Central Venous Catheter Placement also create higher-value opportunities through specialized connectors, extension sets, securement, and filters. Companies increasingly benefit from offering several components as one validated system because this reduces procurement complexity for hospitals. Future capital allocation is expected to favor manufacturers capable of combining high-volume disposables with advanced vascular-access products and infusion-pump compatibility.

New Product Development

New product development in the IV Tubing Sets and Accessories Market is increasingly focused on automatic air management, closed pathways, safer materials, and simplified setup. Modern administration sets incorporate AirStop filters designed to maintain the fluid column when an IV container empties, reducing the need for line repriming. Current configurations offer approximately 24 mL to 30 mL priming volumes and 264 cm to 340 cm tubing lengths, depending on connector and filter design. Sets can integrate 2 or 3 needleless access points, backcheck valves, removable stopcocks, and 0.2-micron filters while remaining free from selected plasticizers. Peripheral systems are also being designed as all-in-one devices combining approximately 4 separate access components. The overall direction is toward fewer manual assembly steps and lower opportunity for contamination or disconnection.

Specialty infusion and long-duration vascular access are creating a second development pathway. PICC products increasingly use pressure-injectable polyurethane, multiple lumen choices, and kits tailored to nursing or interventional radiology workflows. Extension sets can support up to approximately 300 psi and 10 mL per second for selected pressure-injection applications. Drug-specific administration sets are being developed with different tubing materials and filters because medications such as lipid emulsions or chemotherapy agents can require specialized compatibility. Smart-pump tubing is also being optimized for delivery accuracy over defined operating periods, including use durations reaching approximately 96 hours under specified conditions. Future products are expected to incorporate anti-kink materials, lower priming volume, closed flushing, automatic occlusion monitoring, and more environmentally preferred polymers.

Five Recent Developments

August 2026: B Braun Melsungen expanded availability of CARESAFE administration configurations incorporating AirStop technology, multiple needleless access sites, approximately 20 drops per mL delivery, and PVC-free or DEHP-free construction.
July 2026: Poly Medicure broadened its advanced infusion portfolio with double-chamber auto-air-stop and automatic priming configurations designed to reduce air entry and simplify routine IV preparation workflows.
April 2025: Poly Medicure updated its technical infusion portfolio with multiple PVC-free sets, 0.2-micron filtered configurations, needle-free Y-sites, and several advanced administration-set variants for specialized therapy.
October 2024: Baxter International expanded compatibility guidance for its infusion platforms and non-DEHP administration sets, including defined operating parameters for pump-assisted therapy and specialty medication delivery.
April 2024: Baxter International strengthened its Novum IQ compatible administration-set portfolio, supporting smart infusion with delivery rates extending to approximately 1,200 mL per hour and defined set performance up to 96 hours.

Report Coverage

This IV Tubing Sets and Accessories Market report evaluates industry conditions across 2025, the 2026 base period, and the forecast horizon through 2035. The analysis incorporates the supplied 5.5% CAGR and examines Peripheral Intravenous Catheter Insertion, Central Venous Catheter Placement, and PICC Line Insertion. Product segmentation estimates Peripheral Intravenous Catheter Insertion at approximately 51% market share, Central Venous Catheter Placement at 31%, and PICC Line Insertion at 18%. Application coverage includes Hospitals at approximately 48%, Ambulatory Surgical Centers at 15%, Specialized Clinics at 13%, Skilled Nursing Facilities at 10%, Long Term Care Centers at 8%, and Others at 6%. The assessment covers primary tubing, extension sets, filters, needleless connectors, stopcocks, clamps, closed catheters, central access, PICCs, pump compatibility, air management, and specialty materials.

Regional analysis covers North America with approximately 39% market share, Europe with 28%, Asia Pacific with 25%, and Latin America, Middle East & Africa with 8%. Competitive coverage includes Baxter International, Hospira (Pfizer), Becton Dickinson (CareFusion), B Braun Melsungen, Fresenius Kabi, Smiths Medical, C.R. Bard, ICU Medical, Zyno Medical, Nipro, Poly Medicure, Vygon, Health Line International, Perfect Medical, and Dynarex. Current technologies include closed systems integrating approximately 4 components, peripheral catheter dwell approaching 144 hours in selected configurations, administration tubing exceeding 300 cm, pressure injection near 300 psi, filters as fine as 0.2 micron, and pump delivery rates approaching 1,200 mL per hour. Market development is increasingly shaped by infection prevention, infusion accuracy, outpatient care, nursing efficiency, safer materials, smart pumps, long-duration vascular access, and recurring disposable demand.

IV Tubing Sets and Accessories Market Report Coverage
REPORT COVERAGE	DETAILS
Market Size Value In	US$ 895.99 Million in 2026
Market Size Value By	US$ 1461.32 Million by 2035
Growth Rate	CAGR of 5.5 % from 2026 to 2035
Forecast Period	2026 to 2035
Base Year	2025
Historical Data Available	2021-2024
Regional Scope	Global
Segments Covered	Type and Application

Table of Content

Methodology

Inquire Before Buying

Check Discount

Request Sample

What will be the projected value of IV Tubing Sets and Accessories Market by 2035?

The IV Tubing Sets and Accessories Market is projected to reach USD 1461.32 Million by 2035, expanding at a steady pace during the forecast period. Market growth is supported by rising demand, technological advancements, and increasing adoption across major end-use industries worldwide.
What is the expected CAGR of the IV Tubing Sets and Accessories Market during 2026-2035?

The IV Tubing Sets and Accessories Market is expected to grow at a CAGR of 5.5% during the forecast period from 2026 to 2035.
Which companies are leading the IV Tubing Sets and Accessories Market?

Key players in the IV Tubing Sets and Accessories Market market include Baxter International, Hospira (Pfizer), Becton Dickinson (CareFusion), B Braun Melsungen, Fresenius Kabi, Smiths Medical, C.R. Bard, ICU Medical, Zyno Medical, Nipro, Poly Medicure, Vygon, Health Line International, Perfect Medical, Dynarex
How large was the IV Tubing Sets and Accessories Market in 2025?

The IV Tubing Sets and Accessories Market was valued at USD 849.28 Million in 2025, reflecting strong demand and continued adoption across major industries.